These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24115476)

  • 1. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.
    Cheung WW; Ding W; Gunta SS; Gu Y; Tabakman R; Klapper LN; Gertler A; Mak RH
    J Am Soc Nephrol; 2014 Jan; 25(1):119-28. PubMed ID: 24115476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia.
    Gonzalez A; Cheung WW; Perens EA; Oliveira EA; Gertler A; Mak RH
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis.
    Mak RH; Cheung WW; Solomon G; Gertler A
    Curr Pharm Des; 2018; 24(9):1012-1018. PubMed ID: 29366406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting the therapeutic potential of leptin signaling in cachexia.
    Mak RH; Cheung WW; Gertler A
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):352-7. PubMed ID: 25259544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D ameliorates adipose browning in chronic kidney disease cachexia.
    Cheung WW; Ding W; Hoffman HM; Wang Z; Hao S; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Lieber RL; Mak RH
    Sci Rep; 2020 Aug; 10(1):14175. PubMed ID: 32843714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Effects of 25-Hydroxyvitamin D
    Mak RH; Querfeld U; Gonzalez A; Gunta S; Cheung WW
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
    Cheung WW; Mak RH
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1315-24. PubMed ID: 22914778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia.
    Cheung WW; Zheng R; Hao S; Wang Z; Gonzalez A; Zhou P; Hoffman HM; Mak RH
    Sci Rep; 2021 Jul; 11(1):15141. PubMed ID: 34302016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin and inflammation-associated cachexia in chronic kidney disease.
    Mak RH; Cheung W; Cone RD; Marks DL
    Kidney Int; 2006 Mar; 69(5):794-7. PubMed ID: 16518340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth Hormone Improves Adipose Tissue Browning and Muscle Wasting in Mice with Chronic Kidney Disease-Associated Cachexia.
    Mak RH; Gunta S; Oliveira EA; Cheung WW
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.
    Cheung WW; Hao S; Wang Z; Ding W; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Hoffman HM; Lieber RL; Mak RH
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):120-134. PubMed ID: 31721480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease.
    Sun L; Si M; Liu X; Choi JM; Wang Y; Thomas SS; Peng H; Hu Z
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):962-974. PubMed ID: 30043444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.
    Zhu X; Callahan MF; Gruber KA; Szumowski M; Marks DL
    J Clin Invest; 2020 Sep; 130(9):4921-4934. PubMed ID: 32544087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
    Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.
    Deboer MD; Zhu X; Levasseur PR; Inui A; Hu Z; Han G; Mitch WE; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL
    Endocrinology; 2008 Feb; 149(2):827-35. PubMed ID: 18039782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting interleukin-1 for reversing fat browning and muscle wasting in infantile nephropathic cystinosis.
    Cheung WW; Hao S; Zheng R; Wang Z; Gonzalez A; Zhou P; Hoffman HM; Mak RH
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1296-1311. PubMed ID: 34196133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic and local mechanisms leading to cachexia in cancer].
    Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
    Asp ML; Tian M; Kliewer KL; Belury MA
    Cancer Biol Ther; 2011 Dec; 12(11):957-65. PubMed ID: 22104958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
    Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.